How big is Intuitive Surgical, Inc.?

As of Jun 18, Intuitive Surgical, Inc. has a market capitalization of $183.55 billion, with net sales of $8.71 billion and a net profit of $2.49 billion over the latest four quarters.

Market Cap: As of Jun 18, Intuitive Surgical, Inc. has a market capitalization of 183,549.56 million, classifying it as a Large Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Intuitive Surgical, Inc. reported net sales of 8,714.90 million and a net profit of 2,493.80 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 16,433.70 million and total assets of 18,838.60 million.

What does Intuitive Surgical, Inc. do?

Intuitive Surgical, Inc. designs and manufactures da Vinci Surgical Systems and related instruments in the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of $2.25 billion and a net profit of $704 million, with a market cap of approximately $183.55 billion.

Overview:<BR>Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci Surgical Systems and related instruments and accessories in the Pharmaceuticals & Biotechnology industry, categorized as a large-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 2,253 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 704 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 183,549.56 Million (Large Cap)<BR><BR>Key Metrics:<BR>P/E: 80.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.26 <BR>Return on Equity: 14.61% <BR>Price to Book: 10.73<BR><BR>Contact Details:<BR>Address: 1020 Kifer Rd, SUNNYVALE CA: 94086-5301 <BR>Tel: 1 408 5232100 <BR>Website: https://www.intuitivesurgical.com/

Should I buy, sell or hold Intuitive Surgical, Inc.?

Who are in the management team of Intuitive Surgical, Inc.?

As of March 2022, the management team of Intuitive Surgical, Inc. includes Dr. Craig Barratt (Chairman), Dr. Gary Guthart (CEO), and several independent directors: Mr. Joseph Beery, Ms. Amal Johnson, Dr. Don Kania, Dr. Amy Ladd, and Mr. Keith Leonard. They are responsible for the company's strategic direction and operations.

As of March 2022, the management team of Intuitive Surgical, Inc. includes the following individuals:<BR><BR>- Dr. Craig Barratt, Chairman of the Board<BR>- Dr. Gary Guthart, President, Chief Executive Officer, and Director<BR>- Mr. Joseph Beery, Director<BR>- Ms. Amal Johnson, Independent Director<BR>- Dr. Don Kania, Independent Director<BR>- Dr. Amy Ladd, Independent Director<BR>- Mr. Keith Leonard, Independent Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

Is Intuitive Surgical, Inc. overvalued or undervalued?

As of October 24, 2025, Intuitive Surgical, Inc. is considered expensive due to high valuation ratios compared to peers, despite a strong 3-year return of 148.11%, although its year-to-date return of 4.70% lags behind the S&P 500's 15.47%.

As of 24 October 2025, the valuation grade for Intuitive Surgical, Inc. has moved from very expensive to expensive. The company appears to be overvalued based on its high valuation ratios, including a P/E ratio of 80, a Price to Book Value of 11.67, and an EV to EBITDA of 66.13. In comparison, peers such as Abbott Laboratories and Thermo Fisher Scientific, Inc. have significantly lower P/E ratios of 18.36 and 30.06, respectively, indicating that Intuitive Surgical is trading at a premium relative to its industry.<BR><BR>Despite the overvaluation, Intuitive Surgical has shown strong recent performance, with a 3-year return of 148.11%, which outpaces the S&P 500's return of 78.85% over the same period. However, its year-to-date return of 4.70% lags behind the S&P 500's 15.47%, reinforcing the notion that the stock may be overvalued in the current market context.

Is Intuitive Surgical, Inc. technically bullish or bearish?

As of October 24, 2025, Intuitive Surgical's technical trend is neutral with mixed signals, showing mild bullishness on the weekly MACD and Bollinger Bands, but bearishness on daily moving averages and KST, while it has outperformed the S&P 500 recently but lags in year-to-date and one-year returns, suggesting a cautious approach.

As of 24 October 2025, the technical trend for Intuitive Surgical, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish. Bollinger Bands show bullish signals for both weekly and monthly periods. However, moving averages are mildly bearish on the daily timeframe, and KST is bearish for both weekly and monthly periods. The Dow Theory indicates a mildly bullish stance on the weekly but mildly bearish on the monthly. <BR><BR>In terms of performance, Intuitive Surgical has significantly outperformed the S&P 500 over the past week (22.50% vs. 1.92%) and month (23.09% vs. 2.32%), but it lags behind in year-to-date (4.70% vs. 15.47%) and one-year returns (6.82% vs. 16.90%). Overall, the mixed indicators suggest a cautious approach.